{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:39:31Z","timestamp":1760549971126,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25CA116339"],"award-info":[{"award-number":["R25CA116339"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RCS 91-408","CDA 13-025 to"],"award-info":[{"award-number":["RCS 91-408","CDA 13-025 to"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10549-016-3747-6","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T06:21:34Z","timestamp":1457677294000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer"],"prefix":"10.1007","volume":"156","author":[{"given":"Devon K.","family":"Check","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E.","family":"Reeder-Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan M.","family":"Basch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah L.","family":"Zullig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacie B.","family":"Dusetzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"issue":"11","key":"3747_CR1","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1002\/cncr.11408","volume":"97","author":"JT Hickok","year":"2003","unstructured":"Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR (2003) Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer 97(11):2880\u20132886. doi:\n                    10.1002\/cncr.11408","journal-title":"Cancer"},{"key":"3747_CR2","unstructured":"National Cancer Institute (2014) Nausea and vomiting. \n                    http:\/\/www.cancer.gov\/cancertopics\/pdq\/supportivecare\/nausea\/HealthProfessional\n                    \n                  . Accessed 18 Feb 2015"},{"issue":"5","key":"3747_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","volume":"15","author":"L Cohen","year":"2007","unstructured":"Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497\u2013503. doi:\n                    10.1007\/s00520-006-0173-z","journal-title":"Support Care Cancer"},{"issue":"27","key":"3747_CR4","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","volume":"24","author":"B Bloechl-Daum","year":"2006","unstructured":"Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24(27):4472\u20134478. doi:\n                    10.1200\/JCO.2006.05.6382","journal-title":"J Clin Oncol"},{"issue":"10","key":"3747_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00520-004-0662-x","volume":"12","author":"A Glaus","year":"2004","unstructured":"Glaus A, Knipping C, Morant R, Bohme C, Lebert B, Beldermann F, Glawogger B, Ortega PF, Husler A, Deuson R (2004) Chemotherapy-induced nausea and vomiting in routine practice: a European perspective. Support Care Cancer 12(10):708\u2013715. doi:\n                    10.1007\/s00520-004-0662-x","journal-title":"Support Care Cancer"},{"issue":"1","key":"3747_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00520-009-0797-x","volume":"19","author":"TA Burke","year":"2011","unstructured":"Burke TA, Wisniewski T, Ernst FR (2011) Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting. Support Care Cancer 19(1):131\u2013140. doi:\n                    10.1007\/s00520-009-0797-x","journal-title":"Support Care Cancer"},{"key":"3747_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/CE.S6012","volume":"5","author":"P Langford","year":"2010","unstructured":"Langford P, Chrisp P (2010) Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting. Core Evid 5:77\u201390","journal-title":"Core Evid"},{"issue":"31","key":"3747_CR8","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189\u20134198. doi:\n                    10.1200\/JCO.2010.34.4614","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"3747_CR9","doi-asserted-by":"publisher","first-page":"v232","DOI":"10.1093\/annonc\/mdq194","volume":"21","author":"F Roila","year":"2010","unstructured":"Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D, Group EMGW (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232\u2013243. doi:\n                    10.1093\/annonc\/mdq194","journal-title":"Ann Oncol"},{"key":"3747_CR10","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology, Anti-emesis. Version 1.2012. \n                    http:\/\/www.medicine.wisc.edu\/~williams\/anti-emesis.pdf\n                    \n                  . Accessed 18 Feb 2015"},{"key":"3747_CR11","unstructured":"Center for Medicare and Medicaid Services. Medicare Plan Finder. \n                    http:\/\/www.medicare.gov\/find-a-plan\/questions\/home.aspx\n                    \n                  . Accessed 7 Oct 2015"},{"issue":"7","key":"3747_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/cncr.27899","volume":"119","author":"DR Gomez","year":"2013","unstructured":"Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS (2013) Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer 119(7):1428\u20131436. doi:\n                    10.1002\/cncr.27899","journal-title":"Cancer"},{"issue":"Suppl 4","key":"3747_CR13","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.2105\/AJPH.2014.302079","volume":"104","author":"CA Samuel","year":"2014","unstructured":"Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL (2014) Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health 104(Suppl 4):S562\u2013S571. doi:\n                    10.2105\/AJPH.2014.302079","journal-title":"Am J Public Health"},{"issue":"1","key":"3747_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1023\/A:1025481505537","volume":"81","author":"JJ Griggs","year":"2003","unstructured":"Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW (2003) Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81(1):21\u201331. doi:\n                    10.1023\/A:1025481505537","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"3747_CR15","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/cncr.28801","volume":"120","author":"DA John","year":"2014","unstructured":"John DA, Kawachi I, Lathan CS, Ayanian JZ (2014) Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium. Cancer 120(20):3178\u20133191. doi:\n                    10.1002\/cncr.28801","journal-title":"Cancer"},{"issue":"3","key":"3747_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/cncr.26312","volume":"118","author":"CC Reyes-Gibby","year":"2012","unstructured":"Reyes-Gibby CC, Anderson KO, Shete S, Bruera E, Yennurajalingam S (2012) Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks. Cancer 118(3):856\u2013863. doi:\n                    10.1002\/cncr.26312","journal-title":"Cancer"},{"issue":"6","key":"3747_CR17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jpainsymman.2014.02.005","volume":"48","author":"KA Martinez","year":"2014","unstructured":"Martinez KA, Snyder CF, Malin JL, Dy SM (2014) Is race\/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manage 48(6):1050\u20131059. doi:\n                    10.1016\/j.jpainsymman.2014.02.005","journal-title":"J Pain Symptom Manage"},{"issue":"16","key":"3747_CR18","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1200\/JCO.2011.39.2381","volume":"30","author":"MJ Fisch","year":"2012","unstructured":"Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS (2012) Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol 30(16):1980\u20131988. doi:\n                    10.1200\/JCO.2011.39.2381","journal-title":"J Clin Oncol"},{"issue":"6","key":"3747_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1188\/07.ONF.1121-1128","volume":"34","author":"JA McNeill","year":"2007","unstructured":"McNeill JA, Reynolds J, Ney ML (2007) Unequal quality of cancer pain management: disparity in perceived control and proposed solutions. Oncol Nurs Forum 34(6):1121\u20131128. doi:\n                    10.1188\/07.ONF.1121-1128","journal-title":"Oncol Nurs Forum"},{"key":"3747_CR20","doi-asserted-by":"publisher","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Medical care 40 (8 Suppl):IV-3-18. doi:\n                    10.1097\/01.MLR.0000020942.47004.03","DOI":"10.1097\/01.MLR.0000020942.47004.03"},{"issue":"1","key":"3747_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/annonc\/mdj078","volume":"17","author":"F Roila","year":"2006","unstructured":"Roila F, Hesketh PJ, Herrstedt J, Antiemetic Subcommitte of the Multinational Association of Supportive Care in C (2006) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17(1):20\u201328. doi:\n                    10.1093\/annonc\/mdj078","journal-title":"Ann Oncol"},{"issue":"18","key":"3747_CR22","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","volume":"24","author":"MG Kris","year":"2006","unstructured":"Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24(18):2932\u20132947. doi:\n                    10.1200\/JCO.2006.06.9591","journal-title":"J Clin Oncol"},{"issue":"12","key":"3747_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258\u20131267","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"3747_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G (2004) A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159(7):702\u2013706","journal-title":"Am J Epidemiol"},{"key":"3747_CR25","doi-asserted-by":"crossref","unstructured":"Biggers A, Neuner J, Smith E, Pezzin L, Laud P, Charlson JA, Smallwood A (2014) Medicare Part D low-income subsidy and disparities in breast cancer treatment. J Clin Oncol 32 (suppl 30, abstrat 2)","DOI":"10.1200\/jco.2014.32.30_suppl.2"},{"issue":"5","key":"3747_CR26","doi-asserted-by":"publisher","first-page":"w630","DOI":"10.1377\/hlthaff.26.5.w630","volume":"26","author":"P Neuman","year":"2007","unstructured":"Neuman P, Strollo MK, Guterman S, Rogers WH, Li A, Rodday AM, Safran DG (2007) Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff 26(5):w630\u2013w643. doi:\n                    10.1377\/hlthaff.26.5.w630","journal-title":"Health Aff"},{"key":"3747_CR27","unstructured":"Institute of Medicine (2002) Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC"},{"issue":"3","key":"3747_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1475-6773.2010.01100.x","volume":"45","author":"B Le Cook","year":"2010","unstructured":"Le Cook B, McGuire TG, Lock K, Zaslavsky AM (2010) Comparing methods of racial and ethnic disparities measurement across different settings of mental health care. Health Serv Res 45(3):825\u2013847. doi:\n                    10.1111\/j.1475-6773.2010.01100.x","journal-title":"Health Serv Res"},{"issue":"5","key":"3747_CR29","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1111\/j.1475-6773.2006.00583.x","volume":"41","author":"TG McGuire","year":"2006","unstructured":"McGuire TG, Alegria M, Cook BL, Wells KB, Zaslavsky AM (2006) Implementing the Institute of Medicine definition of disparities: an application to mental health care. Health Serv Res 41(5):1979\u20132005. doi:\n                    10.1111\/j.1475-6773.2006.00583.x","journal-title":"Health Serv Res"},{"issue":"1","key":"3747_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J","volume":"88","author":"SA Joslyn","year":"2000","unstructured":"Joslyn SA, West MM (2000) Racial differences in breast carcinoma survival. Cancer 88(1):114\u2013123","journal-title":"Cancer"},{"issue":"17","key":"3747_CR31","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archinte.162.17.1985","volume":"162","author":"LX Clegg","year":"2002","unstructured":"Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK (2002) Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 162(17):1985\u20131993","journal-title":"Arch Intern Med"},{"issue":"9","key":"3747_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/jnci\/86.9.705","volume":"86","author":"RM Elledge","year":"1994","unstructured":"Elledge RM, Clark GM, Chamness GC, Osborne CK (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86(9):705\u2013712","journal-title":"J Natl Cancer Inst"},{"key":"3747_CR33","unstructured":"Kaiser Family Foundation. Medicare at a Glance. \n                    http:\/\/kff.org\/medicare\/fact-sheet\/medicare-at-a-glance-fact-sheet\/\n                    \n                  . Accessed 03 Mar 2015"},{"issue":"10","key":"3747_CR34","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1377\/hlthaff.2011.0027","volume":"30","author":"AK Jha","year":"2011","unstructured":"Jha AK, Orav EJ, Epstein AM (2011) Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health Aff 30(10):1904\u20131911. doi:\n                    10.1377\/hlthaff.2011.0027","journal-title":"Health Aff"},{"key":"3747_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv130","author":"JM Neuner","year":"2015","unstructured":"Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE (2015) The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. J Natl Cancer Inst. doi:\n                    10.1093\/jnci\/djv130","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3747_CR36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF03404301","volume":"92","author":"DD Sin","year":"2001","unstructured":"Sin DD, Svenson LW, Man SF (2001) Do area-based markers of poverty accurately measure personal poverty? Can J Public Health 92(3):184\u2013187","journal-title":"Can J Public Health"},{"issue":"6","key":"3747_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1047-2797(01)00221-6","volume":"11","author":"AV Diez-Roux","year":"2001","unstructured":"Diez-Roux AV, Kiefe CI, Jacobs DR Jr, Haan M, Jackson SA, Nieto FJ, Paton CC, Schulz R (2001) Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol 11(6):395\u2013405","journal-title":"Ann Epidemiol"},{"issue":"13","key":"3747_CR38","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1200\/JCO.2008.21.1532","volume":"27","author":"MJ Hassett","year":"2009","unstructured":"Hassett MJ, Griggs JJ (2009) Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol 27(13):2120\u20132121. doi:\n                    10.1200\/JCO.2008.21.1532","journal-title":"J Clin Oncol"},{"issue":"20","key":"3747_CR39","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/jnci\/djg073","volume":"95","author":"D Hershman","year":"2003","unstructured":"Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI (2003) Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 95(20):1545\u20131548","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"3747_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2008.19.1163","volume":"27","author":"DL Hershman","year":"2009","unstructured":"Hershman DL, Unger JM, Barlow WE, Hutchins LF, Martino S, Osborne CK, Livingston RB, Albain KS (2009) Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814\/S8897. J Clin Oncol 27(13):2157\u20132162. doi:\n                    10.1200\/JCO.2008.19.1163","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3747-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3747-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3747-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:12:53Z","timestamp":1589721173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3747-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3747"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3747-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2016,3,11]]},"assertion":[{"value":"7 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}